Thomas Gad Y M Abs Therapeutics, Inc. (YMAB) insider trading activity

YMAB Quotes by TradingView

Thomas Gad is CHIEF BUSINESS OFFICER of Y-mAbs Therapeutics, Inc.. Currently has a direct ownership of 158,700 shares of YMAB, which is worth approximately $2.11 Million. The most recent transaction as insider was on Jan 19, 2021, when has been sold 7,000 shares (Common Stock) at a price of $46.51 per share, resulting in proceeds of $325,570. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 159K
0% 3M change
75.36% 12M change
Total Value Held $2.11 Million

Thomas Gad Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 19 2021
SELL
Open market or private sale
$325,570 $46.51 p/Share
7,000 Reduced 100.0%
0 Common Stock
Jan 19 2021
BUY
Exercise of conversion of derivative security
$14,000 $2.0 p/Share
7,000 Added 50.0%
7,000 Common Stock
Jan 05 2021
SELL
Open market or private sale
$345,520 $49.36 p/Share
7,000 Reduced 100.0%
0 Common Stock
Jan 05 2021
BUY
Exercise of conversion of derivative security
$14,000 $2.0 p/Share
7,000 Added 50.0%
7,000 Common Stock
Dec 28 2020
SELL
Open market or private sale
$363,860 $51.98 p/Share
7,000 Reduced 100.0%
0 Common Stock
Dec 28 2020
BUY
Exercise of conversion of derivative security
$14,000 $2.0 p/Share
7,000 Added 50.0%
7,000 Common Stock
Dec 16 2020
SELL
Open market or private sale
$371,070 $53.01 p/Share
7,000 Reduced 100.0%
0 Common Stock
Dec 16 2020
BUY
Exercise of conversion of derivative security
$14,000 $2.0 p/Share
7,000 Added 50.0%
7,000 Common Stock
Dec 11 2020
SELL
Open market or private sale
$2,558,500 $51.17 p/Share
50,000 Reduced 100.0%
0 Common Stock
Dec 11 2020
BUY
Exercise of conversion of derivative security
$100,000 $2.0 p/Share
50,000 Added 50.0%
50,000 Common Stock
Dec 10 2020
SELL
Open market or private sale
$2,537,500 $50.75 p/Share
50,000 Reduced 100.0%
0 Common Stock
Dec 10 2020
BUY
Exercise of conversion of derivative security
$100,000 $2.0 p/Share
50,000 Added 50.0%
50,000 Common Stock
TG

Thomas Gad

CHIEF BUSINESS OFFICER
New York, NY

Track Institutional and Insider Activities on YMAB

Follow Y-mAbs Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells YMAB shares.

Notify only if

Insider Trading

Get notified when an Y M Abs Therapeutics, Inc. insider buys or sells YMAB shares.

Notify only if

News

Receive news related to Y-mAbs Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on YMAB